Literature DB >> 24764038

A novel spectral-domain optical coherence tomography model to estimate changes in vitreomacular traction syndrome.

Marco Codenotti1, Lorenzo Iuliano, Giovanni Fogliato, Giuseppe Querques, Francesco Bandello.   

Abstract

PURPOSE: To analyze the course of eyes with vitreomacular traction (VMT), and to find by optical coherence tomography (OCT) possible correlations between vitreomacular interface area changes and the chance of spontaneous VMT resolution.
METHODS: Retrospective analysis of all consecutive patients presenting with VMT over a 24-month period. We introduced a novel OCT evaluation model to assess the vitreomacular interface area. Central foveal thickness (CFT) and best-corrected visual acuity (BCVA) were also analyzed throughout follow-up.
RESULTS: Twenty-six eyes of 18 symptomatic patients were followed for 12.9 ± 4.8 months. Eyes were subdivided into groups according to their clinical course. Six eyes (23%) had a spontaneous resolution of the VMT (group A), and the interface area before its occurrence (39565 ± 26409 μm(2)) was smaller than at study entry (99434 ± 38819 μm(2); p = 0.03). The interface area did not significantly change throughout follow-up in the group that underwent surgery (group B, 11 eyes) and in the group that remained overall stable (group C, 9 eyes). At baseline, the interface area was smaller in group A compared to groups with non-resolved VMT (mean values of group B and C together) (785095 ± 920721 μm(2); p = 0.002). CFT and BCVA did not significantly change in any of the studied groups. Vitreomacular interface area of 101002 μm(2) was identified as the threshold value separating the spontaneous VMT resolution group from the group with non-resolved VMT (p < 0.001).
CONCLUSIONS: The more the vitreomacular interface area reduced over time, the higher was the chance of spontaneous VMT resolution. An area below 101002 μm(2) was the threshold value indicating a higher chance of spontaneous release of VMT.

Entities:  

Mesh:

Year:  2014        PMID: 24764038     DOI: 10.1007/s00417-014-2645-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  30 in total

1.  Vitrectomy for macular pucker and vitreomacular traction syndrome.

Authors:  F Koerner; J Garweg
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

Review 2.  Anatomy and pathology of the vitreo-retinal interface.

Authors:  J Sebag
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

3.  Vitrectomy for macular traction caused by incomplete vitreous separation.

Authors:  W E Smiddy; R G Michels; B M Glaser; S deBustros
Journal:  Arch Ophthalmol       Date:  1988-05

4.  Vitreomacular traction syndrome.

Authors:  Richard F Spaide
Journal:  Retina       Date:  2012-09       Impact factor: 4.256

5.  Spontaneous resolution of vitreomacular traction demonstrated by spectral-domain optical coherence tomography.

Authors:  George P Theodossiadis; Vlassis G Grigoropoulos; Sofia Theodoropoulou; Ioannis Datseris; Panagiotis G Theodossiadis
Journal:  Am J Ophthalmol       Date:  2014-01-18       Impact factor: 5.258

6.  Vitreomacular traction syndrome: a comparison of treatment with intravitreal plasmin enzyme vs spontaneous vitreous separation without treatment.

Authors:  M Codenotti; G Maestranzi; U De Benedetto; G Querques; P Della Valle; L Iuliano; G Fogliato; A D'Angelo; F Bandello
Journal:  Eye (Lond)       Date:  2012-12-14       Impact factor: 3.775

7.  Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography.

Authors:  Dominik Odrobina; Zofia Michalewska; Janusz Michalewski; Krzysztof Dzięgielewski; Jerzy Nawrocki
Journal:  Retina       Date:  2011-02       Impact factor: 4.256

8.  The natural history of tractional cystoid macular edema.

Authors:  Sofia Charalampidou; John Nolan; Stephen Beatty
Journal:  Retina       Date:  2012 Nov-Dec       Impact factor: 4.256

Review 9.  Vitreomacular adhesion and neovascular age-related macular degeneration.

Authors:  Andrew R H Simpson; Robert Petrarca; Timothy L Jackson
Journal:  Surv Ophthalmol       Date:  2012-11       Impact factor: 6.048

10.  Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide.

Authors:  Koh-Hei Sonoda; Taiji Sakamoto; Hiroshi Enaida; Miho Miyazaki; Yoshihiro Noda; Takao Nakamura; Akifumi Ueno; Mitsunobu Yokoyama; Toshiaki Kubota; Tatsuro Ishibashi
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

View more
  7 in total

1.  The design and validation of an optical coherence tomography-based classification system for focal vitreomacular traction.

Authors:  D H W Steel; L Downey; K Greiner; H Heimann; T L Jackson; Z Koshy; D A H Laidlaw; L Wickham; Y Yang
Journal:  Eye (Lond)       Date:  2016-01-15       Impact factor: 3.775

2.  Comparison of the horizontal diameter to a modeled area of traction in eyes with vitreomacular traction: is the diameter close enough to the truth?

Authors:  Christoph Paul; P Krug; H H Müller; J Wachtlin; S Mennel; S Müller; S Schmitz-Valckenberg; T Bertelmann; R G Schumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-28       Impact factor: 3.117

3.  Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study.

Authors:  Irini Chatziralli; George Theodossiadis; Efstratios Parikakis; Ioannis Datseris; Panagiotis Theodossiadis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-05       Impact factor: 3.117

4.  A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit).

Authors:  Peter Stalmans
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-22       Impact factor: 3.117

5.  Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction.

Authors:  Lorenzo Iuliano; Giovanni Fogliato; Roberta Colombo; Riccardo Sacconi; Giuseppe Querques; Francesco Bandello; Marco Codenotti
Journal:  BMC Ophthalmol       Date:  2019-05-10       Impact factor: 2.209

6.  Factors Associated with the Clinical Course of Vitreomacular Traction.

Authors:  Petros Petrou; Evangelia Chalkiadaki; Marie-Helene Errera; Sidath Liyanage; Louisa Wickham; Evangelia Papakonstantinou; Aristotelis Karamaounas; Menelaos Kanakis; Ilias Georgalas; Stylianos Kandarakis; David Charteris
Journal:  J Ophthalmol       Date:  2020-12-21       Impact factor: 1.909

7.  ASSESSMENT OF ANATOMICAL AND FUNCTIONAL OUTCOMES WITH OCRIPLASMIN TREATMENT IN PATIENTS WITH VITREOMACULAR TRACTION WITH OR WITHOUT MACULAR HOLES: Results of OVIID-1 Trial.

Authors:  Ramin Tadayoni; Frank G Holz; Christophe Zech; Xin Liu; Claudio Spera; Peter Stalmans
Journal:  Retina       Date:  2019-12       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.